Literature DB >> 18270261

Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study.

Frederick C W Wu1, Abdelouahid Tajar, Stephen R Pye, Alan J Silman, Joseph D Finn, Terence W O'Neill, Gyorgy Bartfai, Felipe Casanueva, Gianni Forti, Aleksander Giwercman, Ilpo T Huhtaniemi, Krzysztof Kula, Margus Punab, Steven Boonen, Dirk Vanderschueren.   

Abstract

CONTEXT: The cause of declining testosterone (T) in aging men and their relationships with risk factors are unclear.
OBJECTIVE: The objective of the study was to investigate the relationships between lifestyle and health with reproductive hormones in aging men.
DESIGN: This was a baseline cross-sectional survey on 3200 community-dwelling men aged 40-79 yr from a prospective cohort study in eight European countries.
RESULTS: Four predictors were associated with distinct modes of altered function: 1) age: lower free T (FT; -3.12 pmol/liter.yr, P < 0.001) with raised LH, suggesting impaired testicular function; 2) obesity: lower total T (TT; -2.32 nmol/liter) and FT (-17.60 pmol/liter) for body mass index (BMI; > or = 25 to < 30 kg/m(2)) and lower TT (-5.09 nmol/liter) and FT (-53.72 pmol/liter) for BMI 30 kg/m(2) or greater (P < 0.001-0.01, referent: BMI < 25 kg/m(2)) with unchanged/decreased LH, indicating hypothalamus/pituitary dysfunction; 3) comorbidity: lower TT (-0.80 nmol/liter, P < 0.01) with unchanged LH in younger men but higher LH in older men; and 4) smoking: higher SHBG (5.96 nmol/liter, P < 0.001) and LH (0.77 U/liter, P < 0.01) with increased TT (1.31 nmol/liter, P < 0.001) but not FT, compatible with a resetting of T-LH-negative feedback due to elevated SHBG.
CONCLUSIONS: Complex multiple alterations in the hypothalamic-pituitary-testicular axis function exist in aging men against a background of progressive age-related testicular impairment. These changes are differentially linked to specific risk factors. Some risk factors operate independently of but others interact with age, in contributing to the T decline. These potentially modifiable risk factors suggest possible preventative measures to maintain T during aging in men.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18270261     DOI: 10.1210/jc.2007-1972

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  219 in total

Review 1.  Adverse effects of testosterone replacement therapy: an update on the evidence and controversy.

Authors:  Anthony Grech; John Breck; Joel Heidelbaugh
Journal:  Ther Adv Drug Saf       Date:  2014-10

2.  Teasing out the role of aromatase in the healthy and diseased testis.

Authors:  Jenna T Haverfield; Seungmin Ham; Kristy A Brown; Evan R Simpson; Sarah J Meachem
Journal:  Spermatogenesis       Date:  2011-07-01

Review 3.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

4.  Testosterone deficiency and treatment in older men: definition, treatment, pitfalls.

Authors:  Michael Zitzmann
Journal:  Asian J Androl       Date:  2010-08-23       Impact factor: 3.285

5.  Andrology: Identifying late-onset hypogonadism in older men.

Authors:  T Hugh Jones
Journal:  Nat Rev Urol       Date:  2010-11       Impact factor: 14.432

6.  An old emperor finds new clothing: rejuvenation in our time.

Authors:  David J Handelsman
Journal:  Asian J Androl       Date:  2010-11-22       Impact factor: 3.285

7.  Testosterone treatment of older men--why are controversies created?

Authors:  Ronald Swerdloff; Christina Wang
Journal:  J Clin Endocrinol Metab       Date:  2011-01       Impact factor: 5.958

8.  Clinical correlates of sex steroids and gonadotropins in men over the late adulthood: the Framingham Heart Study.

Authors:  R Haring; V Xanthakis; A Coviello; L Sullivan; S Bhasin; H Wallaschofski; J M Murabito; R S Vasan
Journal:  Int J Androl       Date:  2012-05-29

9.  Most multiple myeloma patients have low testosterone.

Authors:  Sonya John; Nidhi Sharma; Douglas W Sborov; Nita Williams; Desirée Jones; Don M Benson; Yvonne A Efebera; Ashley E Rosko; Jennifer Vincent; Craig C Hofmeister
Journal:  Leuk Lymphoma       Date:  2018-10-02

10.  Hypothalamic Response to Kisspeptin-54 and Pituitary Response to Gonadotropin-Releasing Hormone Are Preserved in Healthy Older Men.

Authors:  Ali Abbara; Shakunthala Narayanaswamy; Chioma Izzi-Engbeaya; Alexander N Comninos; Sophie A Clarke; Zainab Malik; Deborah Papadopoulou; Ailish Clobentz; Zubair Sarang; Paul Bassett; Channa N Jayasena; Waljit S Dhillo
Journal:  Neuroendocrinology       Date:  2018-03-15       Impact factor: 4.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.